Skip to main content
. 2021 Jun 1;40:179. doi: 10.1186/s13046-021-01979-7

Fig. 6.

Fig. 6

Exosomal miR-31-5p activated MEK/ERK signaling pathway. a Phosphorylation of MEK and ERK were determined after treatment of HExo. b EMT markers, E-cadherin and vimentin, phosphorylation of MEK and ERK were determined after treatment of HExo and/or miR-31-5p inhibitor. Scratch assays (c) and Transwell invasion assays (d) results after treatment of HExo and/or miR-31-5p inhibitor. Scale bar, 20 μm. Data are represented as the mean ± SD from three independent experiments (**, P<0.01; ***, P<0.001)